Pathogenesis of Liver Fibrosis
The DOI matches its Crossref record; 220 of the 222 references it cites were found in a registry or an index, and 2 are not checked yet.
Abstract
Liver fibrosis is a major cause of morbidity and mortality worldwide due to chronic viral hepatitis and, more recently, from fatty liver disease associated with obesity. Hepatic stellate cell activation represents a critical event in fibrosis because these cells become the primary source of extracellular matrix in liver upon injury. Use of cell-culture and animal models has expanded our understanding of the mechanisms underlying stellate cell activation and has shed new light on genetic regulation, the contribution of immune signaling, and the potential reversibility of the disease. As pathways of fibrogenesis are increasingly clarified, the key challenge will be translating new advances into the development of antifibrotic therapies for patients with chronic liver disease.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“STAT3, a member of the STATs family, is a key transcriptional mediator of cellular processes [43, 44].”
From Saikosaponin b1 Attenuates Liver Fibrosis by Blocking STAT3/Gli1 Interaction and Inducing Gli1 Degradation (2025) · cites this paper as [43]
In the citing paper
“they may also derive from portal fibroblasts, bone marrow-derived cells, circulating fibrocytes, [7] and by the controversially discussed epithelial-tomesenchymal (EMT) [8,9] or endothelial-to-mesenchymal (EndoTM) transition.[10,11]”
From Nuclear receptors in liver fibrosis (2021) · cites this paper as [7]
Citations
Cites
Items 201–222 of 222
Involvement of C/EBP-α gene in in vitro activation of rat hepatic stellate cells
Huang, G., Zhang, J.-S., & Tang, Q.-Q. (2004) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2004.09.196 · Cited by 35
In Vitro and In Vivo Protection of Stellate Cells from Apoptosis by Leptin
Qamar, A., Sheikh, S. Z., Masud, A. J., Jhandier, M. N., Inayat, I., Hakim, W., & Mehal, W. Z. (2006) · Digestive Diseases and Sciences · doi:10.1007/s10620-006-9244-8 · Cited by 34
Epigenetic regulation of hepatic stellate cell activation
Mann, D. A., & Mann, J. (2008) · Journal of Gastroenterology and Hepatology · doi:10.1111/j.1440-1746.2007.05295.x · Cited by 34
Tsuchiya, A., Kamimura, H., Takamura, M., Yamagiwa, S., Matsuda, Y., Sato, Y., Nomoto, M., Ichida, T., & Aoyagi, Y. (2009) · Hepatology Research · doi:10.1111/j.1872-034x.2009.00559.x · Cited by 34
Anania, F. A., Potter, J. J., Rennie-Tankersley, L., & Mezey, E. (1995) · Hepatology · doi:10.1002/hep.1840210624 · Cited by 33
Rat hepatic stellate cells become retinoid unresponsive during activation
Milliano, M. T., & Luxon, B. A. (2005) · Hepatology Research · doi:10.1016/j.hepres.2005.08.007 · Cited by 32
Vincent, K. J., Jones, E., Arthur, M. J. P., Smart, D. E., Trim, J., Wright, M. C., & Mann, D. A. (2001) · Gut · doi:10.1136/gut.49.5.713 · Cited by 32
Görbig, N. M., Ginès, P., Bataller, R., Nicolás, J. M., Garcia-Ramallo, E., Tobías, E., Titos, E., Rey, M. J., Clària, J., Arroyo, V., et al. (1999) · Hepatology · doi:10.1002/hep.510300201 · Cited by 31
Herrmann, J., Borkham‐Kamphorst, E., Haas, U., de Leur, E. V., Fraga, M. F., Esteller, M., Gressner, A. M., & Weiskirchen, R. (2006) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2006.05.076 · Cited by 28
Protective effect of IGF-1 on experimental liver cirrhosis-induced common bile duct ligation.
Cantürk, N. Z., Cantürk, Z., Ozden, M., Dalçık, H., Yardimoğlu, M., & Tülübaş, F. (2003) · PubMed · Cited by 27
Shao, R., & Rockey, D. C. (2002) · Journal of Cellular Physiology · doi:10.1002/jcp.10110 · Cited by 24
Park, E. Y., Shin, S. M., Ma, C. J., Kim, Y. C., & Kim, S. G. (2005) · Planta Medica · doi:10.1055/s-2005-864131 · Cited by 22
Elevated Expression of Tyrosine Kinase DDR2 in Primary Biliary Cirrhosis
Mao, T. K., Kimura, Y., Kenny, T. P., Branch, A. D., Gish, R. G., de Water, J. V., Kung, H., Friedman, S. L., & Gershwin, M. E. (2002) · Autoimmunity · doi:10.1080/0891693021000057784 · Cited by 22
Self-citationCELLUAR PATHOPHYSIOLOGY OF PORTAL HYPERTENSION AND PROSPECTS FOR MANAGEMENT WITH GENE THERAPY
Rockey, D. C. (2001) · Clinics in Liver Disease · doi:10.1016/s1089-3261(05)70195-1 · Cited by 22
Intralobular innervation and lipocyte contractility in the liver
Ueno, T., & Tanikawa, K. (1997) · Nutrition · doi:10.1016/s0899-9007(96)00389-9 · Cited by 21
Senescence of activated stellate cells: Not just early retirement†
Schrader, J., Fallowfield, J., Iredale, J. P., Kowdley, K., McCaughan, G., & Trautwein, C. (2009) · Hepatology · doi:10.1002/hep.22832 · Cited by 21
The Role of Inflammation and Immunity in the Pathogenesis of Liver Fibrosis
Mehal, W. Z., & Friedman, S. L. (2008) · Humana Press eBooks · doi:10.1007/978-1-59745-518-3_10 · Cited by 21
Self-citationFujimiya, T., Liu, J., Kojima, H., Shirafuji, S., Kimurâ, H., & Fujimiya, M. (2009) · American Journal of Physiology-Gastrointestinal and Liver Physiology · doi:10.1152/ajpgi.00055.2009 · Cited by 20
Zvibel, I., Bar-Zohar, D., Kloog, Y., Oren, R., & Reif, S. S. (2007) · Digestive Diseases and Sciences · doi:10.1007/s10620-007-9984-0 · Cited by 19
Tajima, K., Terai, S., Takami, T., Kawaguchi, K., Okita, K., & Sakaida, I. (2007) · Hepatology Research · doi:10.1111/j.1872-034x.2007.00089.x · Cited by 13
Cannabinoides endógenos en la enfermedad hepática: muchos dardos para una sola diana
Reichenbach, V., Ros, J., & Jiménez, W. (2009) · Gastroenterología y Hepatología · doi:10.1016/j.gastrohep.2009.06.010 · Cited by 8
Research works printed but not linked: 15
- 10.1172/jci200112373 · DOI · Paper page
- 10.1055/s-2001-17556 · DOI · Paper page
- Stupack DG., 2007, Oncology, 21, 6
- Hehlgans S, 2007, Biochim. Biophys. Acta, 1775, 163
- Omenetti A, 2008, J. Clin. Investig., 118, 3331
- Pinzani M, 1996, Am. J. Pathol., 148, 785
- Sims DE., 1991, Can. J. Cardiol., 7, 431
- Thimgan MS, 1999, Am. J. Physiol., 277, G137
- 10.1136/gut.2005.088690 · DOI · Paper page
- Gao B., 2005, Cell Mol. Immunol., 2, 92
- Anania FA, 1995, Hepatology, 21, 1640
- Connolly MK, 2009, J. Clin. Investig., 119, 3213
- Seki E, 2009, J. Clin. Investig., 119, 1858
- McCrudden R, 2000, Histol. Histopathol., 15, 1159
- 10.1002/hep.23046 · DOI · Paper page
Cited by
Resolving the fibrotic niche of human liver cirrhosis at single-cell level
Ramachandran, P., Dobie, R., Wilson-Kanamori, J. R., Dora, E. F., Henderson, B. E. P., Luu, N. T., Portman, J. R., Matchett, K. P., Brice, M., Marwick, J. A., et al. (2019) · Nature · doi:10.1038/s41586-019-1631-3 · Cited by 1,784
TGF-β in Hepatic Stellate Cell Activation and Liver Fibrogenesis—Updated 2019
Dewidar, B., Meyer, C., Dooley, S., & Meindl-Beinker, A. N. (2019) · Cells · doi:10.3390/cells8111419 · Cited by 837
“Fibrosis means that an excessive amount of fibrillar extracellular matrix (ECM) proteins, e.g., collagen I and III, is deposited in the space of Disse [1,2].”
BackgroundThe myofibroblast matrix: implications for tissue repair and fibrosis
Klingberg, F., Hinz, B., & White, E. S. (2013) · The Journal of Pathology · doi:10.1002/path.4104 · Cited by 776
The crucial roles of inflammatory mediators in inflammation: A review
Abdulkhaleq, L. A., Assi, M. A., Abdullah, R., Zamri-Saad, M., Taufiq-Yap, Y. H., & Hezmee, M. N. M. (2018) · Veterinary World · doi:10.14202/vetworld.2018.627-635 · Cited by 775
The Role of Cancer-Associated Fibroblasts and Fibrosis in Liver Cancer
Affo, S., Yu, L.-X., & Schwabe, R. F. (2017) · Annual Review of Pathology: Mechanisms of Disease · doi:10.1146/annurev-pathol-052016-100322 · Cited by 757
Metadata
- Authors
- Hernandez-Gea, V., & Friedman, S. L.
- Affiliations
- Division of Liver Diseases, Mount Sinai School of Medicine, New York, New York 10029;
- Icahn School of Medicine at Mount Sinai (US)
- ORCID
- Friedman, Scott L.
- Venue
- Annual Review of Pathology: Mechanisms of Disease
- Publisher
- Annual Reviews
- Published
- 2011-02-28
- Volume
- 6
- Issue
- 1
- Pages
- 425-456
- ISSN
- 1553-4006 (ISSN-L)
- 1553-4014
- OpenAlex
- W2142988890
- Cited by
- 1,809
- References
- 220
- Citations by year
- 2026: 81 · 2025: 123 · 2024: 121 · 2023: 112 · 2022: 148 · 2021: 174 · 2020: 145 · 2019: 119 · 2018: 117 · 2017: 131 · 2016: 136 · 2015: 124 · 2014: 97 · 2013: 76 · 2012: 67
- FWCI
- 10.98
- Type
- journal article
- Language
- en
- Open access
- closed
- Locations
- Annual Review of Pathology Mechanisms of Disease (publishedVersion)
- PubMed (publishedVersion)
- Topics
- Health Sciences › Medicine › Hepatology › Liver physiology and pathology
- Health Sciences › Medicine › Hepatology › Liver Disease Diagnosis and Treatment
- Health Sciences › Medicine › Hepatology › Liver Diseases and Immunity
- Keywords
- liver fibrosis, hepatic stellate cell activation, extracellular matrix, chronic viral hepatitis, hepatic steatosis, obesity, immune signaling, genetic control, fibrosis reversibility, antifibrotic therapy, chronic liver disease
- MeSH terms
- Humans, Liver, Liver Cirrhosis, Signal Transduction
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.